ZICHRON YA'AKOV, Israel - Privately held Can-Fite BioPharma Ltd., focused on targeted treatments for cancer and inflammatory diseases, completed a financing round nearing $12 million, at a post-money valuation of $22 million. (BioWorld International) Read More
